Abstract
Introduction: Increased bone marrow angiogenesis is a characteristic feature of multiple myeloma (MM) and correlates with disease progression. Increased bone marrow angiogenesis at the time of diagnosis, measured in terms of microvessel density (MVD), is a powerful adverse prognostic factor for patients with MM. To better understand the biological basis of this phenomenon and to understand the mechanisms responsible for increased MVD in MM we compared the gene expression profiles of plasma cells from newly diagnosed MM patients with low and high MVD.
Methods: Bone marrow biopsy sections from pts with newly diagnosed MM were studied using CD34 immunostaining and graded as low, intermediate, or high by MVD as previously described. 19 pts each, with low or high MVD were included for this study. RNA was isolated from CD138+ plasma cells of MM patients and analyzed using Affymetrix HG-U133A arrays. To examine differential expression, GC-RMA normalized data was analyzed using GeneSpring 7.2 software and genes with ≥ 2-fold differential expression between high and low MVD samples were identified. The Welch T-test was used to determine the significance of differential expression.
Results and Conclusion: Expression of 42 transcripts was increased ≥ 2-fold in samples with high MVD in comparison to samples with low MVD. Of these transcripts, 14 were found to be significantly increased (P<0.05) using the Welch T-test (see Table 1). Expression of 16 transcripts was decreased ≥ 2-fold in samples with high MVD in comparison to samples with low MVD. Of these transcripts, 6 were found to be significantly decreased (P<0.05) using the Welch T-test (see Table 1). Genes differentially expressed include those involved in inhibiting apoptosis, facilitating IL-6 signaling, ion transport, extracellular matrix interaction, and regulating gene expression. Classical angiogenesis genes including VEGF, FGF, and IGF were not found to be differentially expressed (> 2-fold).
In conclusion, the list of differentially expressed genes reveals many functions relevant to MM disease pathology including proliferation, apoptosis, regulation of gene expression, cytokine signaling, and adhesion. Current studies evaluating the expression and function of these genes in relation to MM may identify factors critical for angiogenesis and MM progression and provide insight for therapeutic intervention.
Gene . | Description . | Fold Change . |
---|---|---|
COL1A2 | collagen, type I, alpha 2 | 3.008 |
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 2.793 |
209183_s_at | chromosome 10 open reading frame 10 | 2.541 |
VIL2 | villin 2 | 2.478 |
IL6ST | interleukin 6 signal transducer (gp130) | 2.404 |
CLIC2 | chloride intracellular channel 2 | 2.364 |
DEPDC6 | DEP domain containing 6 | 2.35 |
PBXIP1 | pre-B-cell leukemia transcription factor interacting protein 1 | 2.337 |
CLIC4 | chloride intracellular channel 4 | 2.334 |
CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | 2.095 |
LIMS1 | LIM and senescent cell antigen-like domains 1 | 2.091 |
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 2.042 |
OAS1 | 2′,5′-oligoadenylate synthetase 1, 40/46kDa | 2.031 |
S100A11 | S100 calcium binding protein A11 | 2.018 |
222378_at | unknown transcribed sequences | 0.496 |
SLC5A3 | mitochondrial ribosomal protein S6 | 0.463 |
213089_at | unknown transcribed sequences | 0.406 |
PDE4B | phosphodiesterase 4B, cAMP-specific | 0.454 |
SVIL | supervillin | 0.386 |
RIPX | rap2 interacting protein x | 0.383 |
Gene . | Description . | Fold Change . |
---|---|---|
COL1A2 | collagen, type I, alpha 2 | 3.008 |
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 2.793 |
209183_s_at | chromosome 10 open reading frame 10 | 2.541 |
VIL2 | villin 2 | 2.478 |
IL6ST | interleukin 6 signal transducer (gp130) | 2.404 |
CLIC2 | chloride intracellular channel 2 | 2.364 |
DEPDC6 | DEP domain containing 6 | 2.35 |
PBXIP1 | pre-B-cell leukemia transcription factor interacting protein 1 | 2.337 |
CLIC4 | chloride intracellular channel 4 | 2.334 |
CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | 2.095 |
LIMS1 | LIM and senescent cell antigen-like domains 1 | 2.091 |
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 2.042 |
OAS1 | 2′,5′-oligoadenylate synthetase 1, 40/46kDa | 2.031 |
S100A11 | S100 calcium binding protein A11 | 2.018 |
222378_at | unknown transcribed sequences | 0.496 |
SLC5A3 | mitochondrial ribosomal protein S6 | 0.463 |
213089_at | unknown transcribed sequences | 0.406 |
PDE4B | phosphodiesterase 4B, cAMP-specific | 0.454 |
SVIL | supervillin | 0.386 |
RIPX | rap2 interacting protein x | 0.383 |
Author notes
Corresponding author
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal